Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|November 7, 2014
Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancerZaker Rana, Robyn A Cyr, Leonard N Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignanciesAnatoly Dritschilo, Chao H Huang, Charles M Rudin, et al.
The New England Journal of Medicine|September 28, 2012
Use of reprogrammed cells to identify therapy for respiratory papillomatosisHang Yuan, Scott Myers, Jingang Wang, et al.
Advances in Experimental Medicine and Biology|October 3, 2019
Discovery of Metabolic Biomarkers Predicting Radiation Therapy Late Effects in Prostate Cancer PatientsAmrita K Cheema, Scott Grindrod, Xiaogang Zhong, et al.
Radiation Oncology (London, England)|February 12, 2014
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancerOnita Bhattasali, Leonard N Chen, Jennifer Woo, et al.
Frontiers in Oncology|February 23, 2017
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year ToxicityIma Paydar, Abigail Pepin, Robyn A Cyr, et al.
The American Journal of Pathology|December 23, 2011
ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cellsXuefeng Liu, Virginie Ory, Sandra Chapman, et al.
Technology in Cancer Research & Treatment|November 13, 2010
Histopathologic effects of hypofractionated robotic radiation therapy on malignant and benign prostate tissueSimeng Suy, Eric Oermann, Heather Hanscom, et al.
Frontiers in Oncology|June 7, 2014
Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancerJennifer A Woo, Leonard N Chen, Aditi Bhagat, et al.
Molecular Cancer Therapeutics|April 18, 2009
AMP-activated protein kinase promotes human prostate cancer cell growth and survivalHyeon Ung Park, Simeng Suy, Malika Danner, et al.
Pageof 11